Summary: DIAGENS-B (02526) reported Revenue of 164.42M(+133.72%); Operating profit of -66.58M(-201.22%); Net profit attributable to owners of -67.14M(-54.78%).
ReportedYoY
Prior YearYoY
RevenueUp YoY
164.42M133.72%
70.35M33.13%
Operating profitDown YoY
-66.58M201.22%
-22.10M44.55%
Net profit attributable to ownersDown YoY
-67.14M54.78%
-43.38M22.70%
Revenue
ReportedUnit: CNY
Operating profit
ReportedUnit: CNY
Net profit attributable to owners
ReportedUnit: CNY
FY2026 Interim Report
Reporting period: 2026.01.01-2026.06.30
Summary: DIAGENS-B (02526) reported Revenue of 108.69M(+21.03%); Net profit attributable to owners of -55.88M(-4070.37%).
ReportedYoY
Prior YearYoY
RevenueUp YoY
108.69M21.03%
89.80M--
Net profit attributable to ownersDown YoY
-55.88M4070.37%
-1.34M--
Revenue
ReportedUnit: CNY
Net profit attributable to owners
ReportedUnit: CNY
Gross marginYoY
Unit: CNY
FY 2023
FY 2024
FY 2025
Profitability
(YoY)
Growth
(YoY)
Asset Quality
(YoY)
Cash Generation
(YoY)
Gross marginYoY
Unit: CNY
H1 2025
H1 2026
Profitability
(YoY)
Growth
(YoY)
Asset Quality
(YoY)
Cash Generation
(YoY)
RevenueYoY
Unit: CNY
FY 2023
FY 2024
FY 2025
Revenue
(YoY)
Cost
(YoY)
Expenses
(YoY)
Interest
(YoY)
Income Tax
(YoY)
Profit
(YoY)
RevenueYoY
Unit: CNY
H1 2025
H1 2026
Revenue
(YoY)
Cost
(YoY)
Expenses
(YoY)
Interest
(YoY)
Income Tax
(YoY)
Profit
(YoY)
Cash and cash equivalentsYoY
Unit: CNY
FY 2023
FY 2024
FY 2025
Assets
(YoY)
Liabilities
(YoY)
Equity
(YoY)
Cash and cash equivalentsYoY
Unit: CNY
H1 2025
H1 2026
Assets
(YoY)
Liabilities
(YoY)
Equity
(YoY)
Net cash from operating activitiesYoY
Unit: CNY
FY 2023
FY 2024
FY 2025
Operating Cash Flow
(YoY)
Investing Cash Flow
(YoY)
Financing Cash Flow
(YoY)
Net Change in Cash
(YoY)
Net cash from operating activitiesYoY
Unit: CNY
H1 2025
H1 2026
Operating Cash Flow
(YoY)
Investing Cash Flow
(YoY)
Financing Cash Flow
(YoY)
Net Change in Cash
(YoY)
Financial data: HKEXnews annual and interim reports; pre-listing years from the prospectus. YoY for ratios is the change in percentage points; ROE and ROA use annual reports only.
About this page
This page shows DIAGENS-B (02526) historical financial statements and corporate actions. Financial data comes from public financial disclosures in HKEX display documents, grouped by reporting period; corporate actions come from HKEXnews announcements.